Table 1. Clinical and genetic characteristics of family BFC.
Code | Sex | Current age (y) | Diagnosis | Age at CPVT diagnosis | Genotype | Diagnostic criterion | SCD/RCA/VT | Syncope | ICD | App ICD Therapy | β-Blocker |
---|---|---|---|---|---|---|---|---|---|---|---|
I-2 | F | 92 | Normal | NA | −/− | NA | No | No | No | NA | No |
II-2 | F | 64 | CPVT | 23 | +/− | Bidirectional VT on EST | Yes | Yes | Yes | Yes | Yes |
II-3 | M | Deceased aged 16 | MVA | NA | NA | Unknown | NA | No | NA | NA | NA |
II-4 | M | 62 | Normal | NA | −/− | No | No | No | No | NA | No |
II-7 | F | 61 | CPVT | 51 | +/− | Polymorphic ectopy on EST | Yes | Yes | Yes | No | Yes |
II-9 | F | 58 | Normal | NA | −/− | No | No | No | No | No | No |
III-1 | F | 41 | Normal | NA | −/− | No | No | No | Yes | No | No |
III-3 | F | 38 | CPVT | 31 | +/− | Polymorphic ectopy on EST | Yes | Yes | Yes | Yes | Yes |
III-5 | M | 34 | Normal | NA | −/− | No | No | No | No | NA | No |
III-11 | M | 33 | Normal | NA | −/− | No | No | No | No | NA | No |
III-13 | F | 32 | CPVT | 28 | +/− | Polymorphic ectopy on EST | No | No | Yes | No | Yes |
IV-1 | F | Deceased aged 5 | CPVT/SCD | 5 | +/− | Unexplained sudden death in CPVT family | Yes | No | No | No | No |
IV-2 | F | 4 | CPVT | 3 | +/− | Polymorphic ectopy on adrenaline challenge | No | No | No | NA | Yes |
IV-6 | F | 1.5 | Possible CPVT | NA | NA | Atrial arrhythmias on adrenaline challenge | No | No | No | NA | Yes |
−/− = no variant identified; +/− = presence of Lysl80Arg variant; App ICD therapy = appropriate implantable cardioverter-defibrillator therapy; CPVT= catecholaminergic polymorphic ventricular tachycardia; EST= exercise stress test; F= female; ICD =implantable cardioverter-defibrillator; M = male; MVA = motor vehicle accident; NA = not applicable; RCA = resuscitated cardiac arrest; SCD = sudden cardiac death;